Decrease in NTproBNP plasma levels indicates clinical improvement of acute decompensated heart failure

American Journal of Emergency Medicine

Volumn 25, Issue 3, 2007, Pages 335-339

  Di Somma, Salvatore ^a   Magrini, Laura ^a   Mazzone, Marinella ^b   De Leva, Raffaella ^a   Tabacco, Fabio ^a   Marino, Rossella ^a   Talucci, Veronica ^a   Ferri, Enrico ^a   Forte, Paola ^a   Cardelli, Patrizia ^a   Gentiloni, Nicola ^b   Pittoni, Valerio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DYSPNEA; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSIVE CRISIS; MALE; MEASUREMENT; PARAMETER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CASE-CONTROL STUDIES; DYSPNEA; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 33847673577     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2006.08.012     Document Type: Article

References (31)

1. Jessup M., and Brozene S. Heart failure. N Engl J Med 348 (2003) 2007-2018
2. Philbin E.F., and Di Salvo T.G. Predictor of hospital readmission for heart failure: development of single risk score based on administrative data. J Am Coll Cardiol 33 (1999) 1560-1566
3. Bleumink G.S., Knetsch A.M., Sturkenboom M.C., et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. Eur Heart J 25 (2004) 1614-1619
4. Maisel A., and McCullough P.A. Cardiac natriuretic peptides: a proteomic window to cardiac function and clinical management. Rev Cardiovasc Med 4 Suppl 4 (2003) S3-S12
5. De Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
6. Maisel A. B-type natriuretic peptide measurements in diagnosis congestive heart failure in the dyspneic emergency department patient. Rev Cardiovasc Med 3 Suppl 4 (2002) S10-S17
7. Rodeheffer R.J. Measuring plasma B-type natriuretic peptide in heart failure. J Am Coll Cardiol 44 (2004) 740-749
8. McCullogh P.A., and Sandeberg K.R. Sorting out evidence on natriuretic peptides. Rev Cardiovasc Med 4 Suppl 4 (2003) S13-S19
9. Morrison L.K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., and Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnoea. J Am Coll Cardiol 39 (2002) 202-209
10. McCullough P.A., Omland T., and Maisel A. B-type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med 4 2 (2003) 72-80
11. Maisel A. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
12. Silver M.A. BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring and therapeutic roles of natriuretic peptides in cardiovascular disease. Heart Fail 8 Suppl 3 (2004) S3-S14
13. Troughton R.W., Frampton C.M., Yandle T.G., et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355 (2000) 1126-1130
14. Richards A.M., Lainchbury J.G., Nicholls M.G., et al. BNP in hormone-guided treatment of heart failure. Trends Endocrinol Metab 13 (2002) 151-155
15. Richards A.M., and Troughton R.W. NT-proBNP in heart failure: therapy decision and monitoring. Eur J Heart Fail 6 (2004) 351-354
16. Bettencourt P. NTproBNP and BNP: biomarkers for heart failure management. Eur J Heart Fail 6 (2004) 359-363
17. Nieminen M.S., Bohm M., Cowie M.R., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
18. Celli B.R. Guidelines on diagnosis of chronic obstructive pulmonary disease. Eur Respir J 13 (2004) 932-946
19. 2003 European Society of Hypertension-European Society of Cardiology Guidelines for management of arterial hypertension. J Hypertens 21 (2003) 1011-1053
20. Mahier D.A., and Wells C.K. Evaluation of clinical methods for rating dyspnea. Chest 93 (1988) 580-586
21. Faulkner L.R., and Bard A.J. Techniques of electrogenerated chemiluminescence. In: Bard A.J. (Ed). Electroanalytical chemistry Vol. 10 (1976), Dekker, New York 1-95
22. Collinson P.O., Barnes S.C., Gaze D.C., et al. Analytical performance of N terminal pro B type natriuretic peptide (NTproBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 15 (2004) 365-368
23. Yeo K.T., Wu A.H., Apple F.S., et al. Multicenter evaluation of the Roche NTproBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 338 (2003) 107-115
24. Kawai K., Hata K., Takaoka H., et al. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta blocker therapy: a potential of hormone-guided treatment. Am Heart J 141 (2004) 925-932
25. Yoshimura M., Mizuno Y., Nakayama M., et al. B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure. Am J Med 112 (2002) 716-720
26. Ferreira A., Bettencourt P., Dias P., et al. Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy. Clin Sci 1 (2001) 100-105
27. Murdock D.R., McDonagh T.A., Byrne J., et al. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomised comparison of the hemodynamic and neuroendocrine effects of tailored vs empirical therapy. Am Heart J 138 (1999) 1126-1132
28. Kazanegra R., Cheng V., Garcia A., et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressure in patients treated for decompensated heart failure: a pilot study. J Card Fail 7 1 (2001) 21-29
29. Johnson W., Omland T., Hall C., et al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilatators for class IV. Heart Fail 39 15 (2002) 1623-1629
30. Zaphirious A., Robb S., Murray-Thomas T., et al. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study. Eur J Heart Fail 7 (2005) 537-541
31. Richards M., Nicholls M.G., Espiner E.A., et al. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol 47 (2006) 52-60